Alzheimer’s Disease: Human Cell Biology of Genetic Variants

Deadline
Feb 10, 2017
OPPORTUNITY NO.
RFA-AG-17-053
MECHANISM
R01
RESEARCH AREA(S)
SYNOPSIS

Human Cell Biology of Genetic Variants in Alzheimer’s Disease

The goal of this FOA is to establish functional genotype-phenotype relationships of genetic variants, suspected of altering the risk of Alzheimer’s disease (AD), in neural cells using human induced pluripotent stem cells or other human cell reprogramming approaches. The causal linkage of AD-associated genetic variants identified in genome-wide association studies and genome sequencing studies to molecular and biological cell phenotypes in human neural cells is expected to give greater insight into molecular targets contributing to the etiology of AD.

Deadlines:

  • Pre-Application Submission: Jan. 10, 2017
  • Application Submission: 5:00 PM local time of applicant organization, Feb. 10, 2017
ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.